Then, human bone samples from the femoral heads of patients undergoing total hip replacement or proximal femur replacement with breast cancer metastases to the bone were stained for RUNX2, OCN, IL-6, and alpha-SMA using multi-plex immunofluorescence (Fig. 5). Here, RUNX2 is linked to breast cancer.